Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
J Mol Med (Berl). 2022 Sep;100(9):1239-1251. doi: 10.1007/s00109-022-02224-0. Epub 2022 Aug 5.
Macrophages in atherosclerotic patients are notably plastic and heterogeneous. Single-cell RNA sequencing (Sc RNA-seq) can provide information about all the RNAs in individual cells, and it is used to identify cell subpopulations in atherosclerosis (AS) and reveal the heterogeneity of these cells. Recently, some findings from Sc RNA-seq experiments have suggested the existence of multiple macrophage subsets in atherosclerotic plaque lesions, and these subsets exhibit significant differences in their gene expression levels and functions. These cells affect various aspects of plaque lesion development, stabilization, and regression, as well as plaque rupture. This article aims to review the content and results of current studies that used RNA-seq to explore the different types of macrophages in AS and the related molecular mechanisms as well as to identify the potential roles of these macrophage types in the pathogenesis of atherosclerotic plaques. Also, this review listed some new therapeutic targets for delaying atherosclerotic lesion progression and treatment based on the experimental results.
动脉粥样硬化患者的巨噬细胞具有显著的可塑性和异质性。单细胞 RNA 测序 (Sc RNA-seq) 可以提供单个细胞中所有 RNA 的信息,用于鉴定动脉粥样硬化 (AS) 中的细胞亚群,并揭示这些细胞的异质性。最近,Sc RNA-seq 实验的一些发现表明,动脉粥样硬化斑块病变中存在多种巨噬细胞亚群,这些亚群在基因表达水平和功能上存在显著差异。这些细胞影响斑块病变发展、稳定和消退以及斑块破裂的各个方面。本文旨在综述目前使用 RNA-seq 技术研究动脉粥样硬化中不同类型巨噬细胞及其相关分子机制的研究内容和结果,并确定这些巨噬细胞类型在动脉粥样硬化斑块发病机制中的潜在作用。此外,还根据实验结果列出了一些用于延缓动脉粥样硬化病变进展和治疗的新的治疗靶点。